The present study include a new developed method of analysis for determination of drug Spironolaction (SP) in some Pharmaceuticals by Spectrofluorometric method. Spironolaction was determined under optimal experimental condition that follows :- The excitation spectrum was (l=351 nm), the emmetion spectrum was (l=518 nm), pH=1, the suitable temperature for reaction 60oC and the optimal time less than (3) minute. The analysis and rang statistical data was:-Linear dynamic rang (1-10) ?g.ml-1, the detection limit (D.L = 0.023 ?g.ml-1), Molar absorptivity (? = 29875 liter mole-1 cm-1), Relative standard deviation (%RSD = 0.78), (%Erel = 3.3) and recovery (Rec = 96.6) percentage. Determination of Spironolactone was accomplished by two methods

In this paper, we define certain subclasses of analytic univalent function associated with quasi-subordination. Some results such as coefficient bounds and Fekete-Szego bounds for the functions belonging to these subclasses are derived.

       In this paper we offer two new subclasses of an open unit disk of r-fold symmetric bi-univalent functions. The Taylor-Maclaurin coefficients  have their coefficient bounds calculated. Furthermore, for functions in , we have solved Fekete-  functional issues. For the applicable classes, there are also a few particular special motivator results.

A new flow injection spectrophotometric method is described for the determination of copper ion Cu(II) in water samples (tap water and river water).The proposed method based on the formation of red complex [Cu(L)2(NO3)2] which has a maximum absorption at λmax=490 nm. Linear range for Cu (II) was from 5-70μg/mL with detection limit 2.55μg/mL. The effect of physical and chemical parameters were evaluated .The proposed method was applied successfully for determination of copper (II) in the tap and river water. [Cu(L)2(NO3)2] complex was prepared in a (2:1) mole ratio as ( reagent: copper (II)).The analytical reagent formed by reaction of thymol with 4-aminoantipyrine at room temperature. The metal complex was characterized by IR, UV-Visi

The technique of adding Carbon Nano-Tubes to What liquids is a new important method used to enhance the thermal properties of liquids such as specific heat and heat capacity.
The experimental part was carried out using water-based nanoparticles such as Carbon Nano Tubes, with different concentrations at (0.1, 0.3, o.5and 0.7wt %) of MWCNT (Multi Wall Carbon Nanotubes) and distilled water as a base, in different temperatures. The change in the value of heat capacity of a liquid was investigated. The value of heat capacity for Nano fluids increased with increasing the Carbon NanoTubes particles,when as compared with the value of heat capacity for distilled water . The best concentration of MWCNTs was improved with heat capacity about 60

In this study, the energy charging mechanism is mathematically modeled to determine the impact of design modifications on the thermofluidic behavior of a phase change material (PCM) filled in a triplex tube containment geometry. The surface area of the middle tube, where the PCM is placed, is supported by single or multi-internal frustum tubes in vertical triplex tubes to increase the performance of the heating and cooling of the system. In addition to the ordinary straight triplex tubes, three more scenarios are considered: (1) changing the middle tube to the frustum tube, (2) changing the inner tube to the frustum tube, and (3) changing both the internal and central tubes to the frustum tubes. The impact of adopting the tube desig

Background: Type 2 diabetes mellitus is a condition characterized by an elevation of oxidative stress, which has been implicated in diabetic progression and its vascular complications. Aim: Assessing the impact of gliclazide modified release (MR) versus glimepiride on oxidative stress markers, glycemic indices, lipid profile, and estimated glomerular filtration rate in uncontrolled type 2 diabetic patients on metformin monotherapy. Methods: This was an observational comparative study conducted in Thi-Qar specialized diabetic, endocrine, and metabolism center. Sixty-six patients were randomized into two groups based on the addition of the sulfonylureas (SUs). Group 1 (33 patients) was on gliclazide MR, whereas Group 2 (33 patients)